Intermediate for Apixaban. Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.


Product Name:                  1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone

Synonyms:                         N/A

CAS Number:                     1267610-26-3

Molecular Weight:            273.334

Molecular Formula:          C15H19N3O2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Nc1ccc(cc1)N1CCC=C(C1=O)N1CCOCC1


  • $207.00
  • Ex Tax: $207.00

Available Options